The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gao, F., Kiesewetter, D. O., Chang, L., Ma, K., Bell, J. M., Rapoport, S. I., & Igarashi, M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.d800056-jlr200 · Cited by 52
RetractedAlberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Increased IRS-1 phosphorylation is observed in insulin resistance and obesity with increased c-Jun N-terminal kinase (JNK) activity [121].”
BackgroundResolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase
Zimmermann, R., Strauss, J. G., Haemmerle, G., Schoiswohl, G., Birner-Gruenberger, R., Riederer, M., Lass, A., Neuberger, G., Eisenhaber, F., Hermetter, A., et al. (2004) · Science · doi:10.1126/science.1100747 · Cited by 2,116
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929 · cited 1×
“even though MMP up-regulation is the hallmark of many inflammatory diseases such as arthritis and atherosclerosis [203].”
BackgroundImportance of n−3 fatty acids in health and disease
Connor, W. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.171s · Cited by 1,344
Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.779 · Cited by 1,221
Cited by
Tocher, D., Betancor, M., Sprague, M., Olsen, R., & Napier, J. (2019) · Nutrients · doi:10.3390/nu11010089 · Cited by 615
“Our understanding of the beneficial effects of dietary EPA and DHA on human health has been based largely on three main lines of evidence including epidemiological studies, randomized controlled trials (RCT), and laboratory studies investigating biochemical and molecular mechanisms that have provided considerable mech…”
BackgroundPérez-Martínez, P., Mikhailidis, D. P., Athyros, V. G., Bullo, M., Couture, P., Covas, M. I., de Koning, L., Delgado-Lista, J., Díaz-López, A., Drevon, C. A., et al. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux014 · Cited by 410
Health benefits of dietary marine DHA/EPA-enriched glycerophospholipids
Zhang, T.-T., Xu, J., Wang, Y.-M., & Xue, C.-H. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.100997 · Cited by 339
α-Linolenic acid: Nutraceutical, pharmacological and toxicological evaluation
Kim, K.-B., Nam, Y. A., Kim, H. S., Hayes, A. W., & Lee, B.-M. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.05.009 · Cited by 314
Hashidate-Yoshida, T., Harayama, T., Hishikawa, D., Morimoto, R., Hamano, F., Tokuoka, S. M., Eto, M., Tamura-Nakano, M., Yanobu-Takanashi, R., Mukumoto, Y., et al. (2015) · eLife · doi:10.7554/elife.06328 · Cited by 270
“They are related to cardiovascular diseases, neuronal functions, metabolic syndromes, and many other pathophysiological events (Poudyal et al., 2011; Baum et al., 2012; Jiao et al., 2014).”
BackgroundRuiz-Núñez, B., Pruimboom, L., Dijck-Brouwer, D. A. J., & Muskiet, F. A. J. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.02.009 · Cited by 246
Temporal changes in human skeletal muscle and blood lipid composition with fish oil supplementation
McGlory, C., Galloway, S. D. R., Hamilton, D. L., McClintock, C., Breen, L., Dick, J. R., Bell, J. G., & Tipton, K. D. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.03.001 · Cited by 130
“Given the potential beneficial impact of increasing the skeletal muscle n-3 PUFA composition on metabolic health [3,7], data that demonstrate a time course increase in skeletal muscle n-3 PUFA composition with fish oil supplementation could therefore provide critical data for clinical and athletic practice.”
BackgroundDietary fat intake, pesticide use, and Parkinson's disease
Kamel, F., Goldman, S. M., Umbach, D. M., Chen, H., Richardson, G., Barber, M. R., Meng, C., Marras, C., Korell, M., Kasten, M., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.09.023 · Cited by 127
Scaglione, S., Di Chiara, T., Daidone, M., & Tuttolomondo, A. (2025) · Nutrients · doi:10.3390/nu17020358 · Cited by 92
Bakaloudi, D. R., Chrysoula, L., Kotzakioulafi, E., Theodoridis, X., & Chourdakis, M. (2021) · Nutrients · doi:10.3390/nu13051514 · Cited by 92
Capel, F., Acquaviva, C., Pitois, E., Laillet, B., Rigaudière, J.-P., Jouve, C., Pouyet, C., Gladine, C., Comte, B., Vianey Saban, C., et al. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.04.003 · Cited by 86
Akrami, A., Nikaein, F., Babajafari, S., Faghih, S., & Yarmohammadi, H. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2017.11.004 · Cited by 85
Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes
Lasselin, J., Layé, S., Dexpert, S., Aubert, A., Gonzalez, C., Gin, H., & Capuron, L. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.03.003 · Cited by 77
Günalan, E., Yaba, A., & Yılmaz, B. (2018) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2018.0077 · Cited by 74
Matravadia, S., Herbst, E. A. F., Jain, S. S., Mutch, D. M., & Holloway, G. P. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00032.2014 · Cited by 46
“Although ALA can be endogenously converted into EPA/DHA, tracer studies have revealed that the conversion efficiency is low ( 8%) (44, 54).”
BackgroundItsiopoulos, C., Marx, W., Mayr, H. L., Tatucu-Babet, O. A., Dash, S. R., George, E. S., Trakman, G. L., Kelly, J. T., Thomas, C. J., & Brazionis, L. (2018) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2018.02.002 · Cited by 37
Apelin/APJ system: A novel therapeutic target for locomotor system diseases
Luo, J., Liu, W., Feng, F., & Chen, L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174286 · Cited by 28
Lu, L., Li, X., Lv, L., Xu, Y., Wu, B., & Huang, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1016943 · Cited by 22
Zulkafli, I. S., Waddell, B. J., & Mark, P. J. (2013) · Endocrinology · doi:10.1210/en.2013-1153 · Cited by 22
“Various mechanisms have been described to explain the capacity of n-3 fatty acids to lower BP, including their antagonism of angiotensin II receptor activation, stimulation of vasodilative eicosanoids, and inhibition of the renin-angiotensin system (27, 28).”
Background(2012) · PubMed · Cited by 19
Diet and Nutrition: Implications to Cardiometabolic Health
Johnson, M. (2019) · Journal of Cardiology and Cardiovascular Sciences · doi:10.29245/2578-3025/2019/2.1168 · Cited by 9
Metadata
- Authors
- Poudyal, H., Panchal, S. K., Diwan, V., & Brown, L.
- Venue
- Progress in Lipid Research
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 50
- Issue
- 4
- Pages
- 372-387
- ISSN
- 0163-7827 (ISSN-L)
- OpenAlex
- W1996063029
- Cited by
- 370
- References
- 226
- FWCI
- 28.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.